Mark Sirgo

Type: Person
Name: Mark Sirgo
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Raleighs BioDelivery Sciences moves diabetes pain gel into final stages of testing

Mark Sirgo, CEO of Raleigh-based BioDelivery Sciences International, which just began enrolling patients in a Phase 3 trial to test a gel that will treat ... ... [Published Big News Network - Apr 04 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

BioDelivery Sciences : Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.

By a News Reporter-Staff News Editor at Pain & Central Nervous System Week -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated ... [Published 4 Traders - Apr 02 2014]
First reported Mar 31 2014 - Updated Mar 31 2014 - 1 reports

BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S.

/PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), ... [Published Fierce CRO - Mar 31 2014]
First reported Mar 28 2014 - Updated Mar 29 2014 - 1 reports

BioDelivery Sciences Announces Commercialization Agreement with Quintiles

BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), BDSI's proposed ... [Published Citybizlist - Mar 28 2014]
First reported Mar 27 2014 - Updated Mar 28 2014 - 3 reports

BioDelivery Sciences picks Quintiles to help launch proposed drug

Posted Mar. 27, 2014 at 8:20 a.m. How BDSI technology works Related Blog Posts Site SearchBy WRALTechWireRaleigh, N.C. — Raleigh-based BioDelivery Sciences (Nasdaq: BDSI ), whichrecently raised $60 million to help commercialize its proposed chronic ... [Published Local Tech Wire - Mar 27 2014]
First reported Mar 14 2014 - Updated Mar 14 2014 - 3 reports

BioDelivery Sciences Provides Business Review And Update In Conjunction With Filing Of Its 2013 Annual Report

RALEIGH, N.C.In 2013, BDSI made important progress in significantly advancing and building its product portfolio in pain and addiction treatment and made meaningful strides in its continuing evolution from a development stage entity to a commercial enterprise. ... [Published TheStreet.com - Mar 14 2014]
First reported Mar 05 2014 - Updated Mar 05 2014 - 1 reports

BioDelivery Sciences to Present at the 26th Annual ROTH Conference

RALEIGH, N.C., March 5, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual ROTH Conference.  The presentation ... [Published PR Newswire: General Business - Mar 05 2014]
First reported Feb 28 2014 - Updated Feb 28 2014 - 1 reports

BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference

RALEIGH, N.C., Feb. 28, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Conference.  ... [Published PR Newswire: Health - Feb 28 2014]

More Content

All (12) | News (10) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Raleighs BioDelivery Sciences moves diabetes pa... [Published Big News Network - Apr 04 2014]
BioDelivery Sciences : Announces Commercializat... [Published 4 Traders - Apr 02 2014]
BioDelivery Sciences Announces Commercializatio... [Published Fierce CRO - Mar 31 2014]
BioDelivery Sciences Announces Commercializatio... [Published Citybizlist - Mar 28 2014]
BioDelivery Sciences picks Quintiles to help la... [Published Local Tech Wire - Mar 27 2014]
BioDelivery Sciences Announces Commercializatio... [Published Digital Journal - Mar 27 2014]
BioDelivery Sciences Announces Commercializatio... [Published Michigan Live - Mar 27 2014]
BioDelivery Sciences Provides Business Review A... [Published TheStreet.com - Mar 14 2014]
BioDelivery Sciences Provides Business Review a... [Published ADVFN UK - Mar 14 2014]
BioDelivery Sciences Provides Business Review a... [Published BusinessWeek - Mar 14 2014]
BioDelivery Sciences to Present at the 26th Ann... [Published PR Newswire: General Business - Mar 05 2014]
BioDelivery Sciences to Present at the Cowen an... [Published PR Newswire: Health - Feb 28 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioDelivery Sciences to Present at the 26th Ann... [Published PR Newswire: General Business - Mar 05 2014]
RALEIGH, N.C., March 5, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual ROTH Conference.  The presentation ...
BioDelivery Sciences to Present at the Cowen an... [Published PR Newswire: Health - Feb 28 2014]
RALEIGH, N.C., Feb. 28, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Conference.  ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.